Biblio Discovery — Demo Discovery Service

33 results for "Henrik Franzyk"

Showing 1–20 · 0.63 seconds · RSS

  1. Journal Article Full text

    Targeting Toxins toward Tumors

    Henrik Franzyk; Søren Brøgger Christensen

    Molecules, Vol. 26 No. 5 · 2021 · English · DOAJ Scopus

    Many cancer diseases, e.g., prostate cancer and lung cancer, develop very slowly. Common chemotherapeutics like vincristine, vinblastine and taxol target cancer cells in their proliferating states. In slowly developing cancer diseases only a minor part of the malignant cells will be in a…

  2. Journal Article Full text

    Preparation of Enzyme-Activated Thapsigargin Prodrugs by Solid-Phase Synthesis

    Tomas Zimmermann; Søren Brøgger Christensen; Henrik Franzyk

    Molecules, Vol. 23 No. 6 · 2018 · English · DOAJ Scopus

    Since cells in solid tumors divide less rapidly than cells in the bone marrow or cells of the immune system, mitotic inhibitors often cause severe side effects when used for treatment of diseases like prostate cancer and breast cancer. One approach to overcome this problem involves attempts at…

  3. Journal Article Full text

    Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs

    Natalia Molchanova; Paul R. Hansen; Henrik Franzyk

    Molecules, Vol. 22 No. 9 · 2017 · English · DOAJ Scopus

    The rapid emergence of multidrug-resistant pathogens has evolved into a global health problem as current treatment options are failing for infections caused by pan-resistant bacteria. Hence, novel antibiotics are in high demand, and for this reason antimicrobial peptides (AMPs) have attracted…

  4. Journal Article Full text

    Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance.

    Line Hein-Kristensen; Henrik Franzyk; Anne Holch et al.

    PLoS ONE, Vol. 8 No. 9 · 2013 · English · DOAJ Scopus

    Antimicrobial peptides (AMPs) and synthetic analogues thereof target conserved structures of bacterial cell envelopes and hence, development of resistance has been considered an unlikely event. However, recently bacterial resistance to AMPs has been observed, and the aim of the present study was to…

    Also available at: PLOS

  5. Journal Article Full text

    Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity

    Ingvill Pedersen Sæbø; Magnar Bjørås; Henrik Franzyk et al.

    International Journal of Molecular Sciences · 2023 · English · OpenAlex Scopus

    In vitro determination of hemolytic properties is a common and important method for preliminary evaluation of cytotoxicity of chemicals, drugs, or any blood-contacting medical device or material. The method itself is relatively straightforward, however, protocols used in the literature vary…

  6. Journal Article

    Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles

    Abhijeet Lokras; Aneesh Thakur; Abishek Wadhwa et al.

    Frontiers in Bioengineering and Biotechnology, Vol. 8 · 2021 · English · DOAJ Scopus

    RNA interference (RNAi) has an unprecedented potential as a therapeutic strategy for reversibly silencing the expression of any gene. Therapeutic delivery of the RNAi mediator, i.e., small interfering RNA (siRNA), can be used to address diseases characterized by gene overexpression, for example…

  7. Journal Article Full text

    The Effects of Structural Alterations in the Polyamine and Amino Acid Moieties of Philanthotoxins on Nicotinic Acetylcholine Receptor Inhibition in the Locust, Schistocerca gregaria

    Victoria L. Luck; David P. Richards; Ashif Y. Shaikh et al.

    Molecules, Vol. 26 No. 22 · 2021 · English · DOAJ Scopus

    Alterations in the polyamine and amino acid (tyrosine) moieties of philanthotoxin-343 (PhTX-343) were investigated for their effects on the antagonism of nicotinic acetylcholine receptors (nAChRs) isolated from the locust (Schistocerca gregaria) mushroom body. Through whole-cell patch-clamp…

  8. Journal Article

    Macrolide Resistance and In Vitro Potentiation by Peptidomimetics in Porcine Clinical Escherichia coli

    Yibing Ma; Mattia Pirolo; Prabha Subramani et al.

    mSphere, Vol. 7 No. 5 · 2022 · English · DOAJ Scopus

    ABSTRACT Escherichia coli is intrinsically resistant to macrolides due to outer membrane impermeability, but may also acquire macrolide resistance genes by horizontal transfer. We evaluated the prevalence and types of acquired macrolide resistance determinants in pig clinical E. coli, and we…

  9. Journal Article

    In vivo Anti-inflammatory Activity of Lipidated Peptidomimetics Pam-(Lys-βNspe)6-NH2 and Lau-(Lys-βNspe)6-NH2 Against PMA-Induced Acute Inflammation

    Bing C. Wu; Sarah L. Skovbakke; Hamid Masoudi et al.

    Frontiers in Immunology, Vol. 11 · 2020 · English · DOAJ Scopus

    Host Defense Peptides (HDPs) are key components of innate immunity that exert antimicrobial, antibiofilm, and immunomodulatory activities in all higher organisms. Synthetic peptidomimetic analogs were designed to retain the desirable pharmacological properties of HDPs while having improved…

  10. Journal Article

    Synergistic combinations of novel polymyxins and rifampicin with improved eradication of colistin-resistant Pseudomonas aeruginosa biofilms

    Johan Storm Jørgensen; Anne Sofie Laulund Siebert; Oana Ciofu et al.

    Biofilm, Vol. 8 · 2024 · English · DOAJ Scopus

    Background: Increased prevalence of antimicrobial resistance coupled with a lack of new antibiotics against Gram-negative bacteria emphasize the imperative for novel therapeutic strategies. Colistin-resistant Pseudomonas aeruginosa constitutes a challenge, where conventional treatment options lack…

  11. Journal Article Full text

    Stereoisomer-Dependent Membrane Association and Capacity for Insulin Delivery Facilitated by Penetratin

    Ditlev Birch; Edward J. Sayers; Malene V. Christensen et al.

    Pharmaceutics, Vol. 15 No. 6 · 2023 · English · DOAJ Scopus

    Cell-penetrating peptides (CPPs), such as penetratin, are often investigated as drug delivery vectors and incorporating d-amino acids, rather than the natural l-forms, to enhance proteolytic stability could improve their delivery efficiency. The present study aimed to compare membrane association…

  12. Journal Article

    Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients

    Natalia Molchanova; Hengzhuang Wang; Paul R. Hansen et al.

    Frontiers in Microbiology, Vol. 10 · 2019 · English · DOAJ Scopus

    Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in patients with cystic fibrosis infection and with a compromised immune system. Emergence of bacterial resistance renders existing antibiotics inefficient, and therefore discovery of new antimicrobial agents is…

  13. Journal Article

    An intracellular release peptide display technology unveils an antimicrobial peptide with low probability for resistance development

    Anna Ebbensgaard; Catrina Olivera; Thomas Bentin et al.

    iScience, Vol. 28 No. 6 · 2025 · English · DOAJ Scopus

    Summary: Discovery of bioactive peptides, including those acting to permeabilize and/or kill bacterial cells (antimicrobial peptides) has drawn extensive interest in recent years. However, current technologies for their identification are limited. To address these limitations, the Intracellular…

  14. Journal Article

    Recent advances in the development of antimicrobial peptides against ESKAPE pathogens

    Cesar Augusto Roque-Borda; Laura Maria Duran Gleriani Primo; Henrik Franzyk et al.

    Heliyon, Vol. 10 No. 11 · 2024 · English · DOAJ Scopus

    Multi-drug resistant ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are a global health threat. The severity of the problem lies in its impact on mortality, therapeutic limitations, the…

  15. Journal Article Full text

    High-Resolution PTP1B Inhibition Profiling Combined with HPLC-HRMS-SPE-NMR for Identification of PTP1B Inhibitors from Miconia albicans

    Rita de Cássia Lemos Lima; Kenneth T. Kongstad; Lucília Kato et al.

    Molecules, Vol. 23 No. 7 · 2018 · English · DOAJ Scopus

    Protein tyrosine phosphatase 1B (PTP1B) is an intracellular enzyme responsible for deactivation of the insulin receptor, and consequently acts as a negative regulator of insulin signal transduction. In recent years, PTP1B has become an important target for controlling insulin resistance and type 2…

  16. Journal Article

    Rational design of synthetic antimicrobial peptides based on the Escherichia coli ShoB toxin

    Ingvill Pedersen Sæbø; Emma Dyhr; Ida Mathilde Marstein Riisnæs et al.

    Scientific Reports, Vol. 15 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Antibiotic resistance is an escalating global concern, necessitating the development of novel antibiotics with unique mechanisms of action, and preferably also with a lowered propensity for resistance development. Type-I Toxin-Antitoxin (TA) systems that are ubiquitous in bacterial genomes…